Trivarx Ltd has released a press release.
Executive Leadership Changes
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- Clinical Study Shows Improvement to Diagnostic Standard
- Preliminary Final Report
- Departure of Managing Director & Chief Executive Officer
- Medibio Submits FDA De Novo Application
- Medibio Receives TGA Approval
Later from TrivarX
- Notice Received Under Section 249D of the Corporations Act
- Medibio Releases Corporate Health Product, ilumen
- Receipt of R&D Tax Incentive Refund
- MEB Signs ilumen Contract with Large Australian Employer
- Medibio Appoints CEO and Managing Director
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX